Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 Mar 1955 |
100 Clinical Results associated with Wrafton Laboratories Ltd.
0 Patents (Medical) associated with Wrafton Laboratories Ltd.
100 Deals associated with Wrafton Laboratories Ltd.
100 Translational Medicine associated with Wrafton Laboratories Ltd.